MONMOUTH JUNCTION, NJ--(Marketwire - October 16, 2007) - MedaSorb Technologies Corporation (OTCBB: MSBT) (FRANKFURT: HQE) announced today that they completed the investigators’ meeting in Berlin, Germany to support the clinical study of MedaSorb’s CytoSorb™ hemoperfusion device.
